Levomilnacipran Hydrochloride | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Levomilnacipran Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 10 USDMF, 4 EU WC, 7 NDC API, 12 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

25 FDF Dossiers, 20 FDA Orange Book, 4 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, EXTENDED RELEASE;ORAL - EQ 120MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 20MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 40MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

3 DKSH, 1 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 1 Actylis, 1 Aeon Procare, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 11 Corel Pharma Chem, 4 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 12 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 2 Microlex e.U, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 2 Roquette, 7 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 3 The Dow Chemical Company, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

47 Coating Systems & Additives, 24 Controlled & Modified Release, 13 Fillers, Diluents & Binders, 12 Film Formers & Plasticizers, 9 Granulation, 7 Solubilizers, 6 Taste Masking, 6 Direct Compression, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Thickeners and Stabilizers, 3 Parenteral, 3 API Stability Enhancers, 2 Co-Processed Excipients, 2 Disintegrants & Superdisintegrants, 2 Lubricants & Glidants, 1 Surfactant & Foaming Agents, 1 Emulsifying Agents, 1 Rheology Modifiers, 1 Chewable & Orodispersible Aids

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 5 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Finished Drug Prices, 4 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

12 US Patents, 4 US Exclusivities, 8 Health Canada Patents

Xls

Filters

Filters

FILTER :

filter Product Reset all filters

4 All

01 4Savella

List of Suppliers

Product Main Page

01

Brand Name : Savella

Pharmtech & Ingredients

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Milnacipran HCl

Main Therapeutic Indication : Fibromyalgia

Currency : USD

2017 Revenue in Millions : 98

2016 Revenue in Millions : 103

Growth (%) : -5

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Savella

Pharmtech & Ingredients

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Milnacipran Hcl

Main Therapeutic Indication : Neurological/Mental Disorders

Currency : USD

2018 Revenue in Millions : 85

2017 Revenue in Millions : 98

Growth (%) : -13%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Savella

Pharmtech & Ingredients

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Milnacipran Hcl

Main Therapeutic Indication : Fibromyalgia

Currency : USD

2016 Revenue in Millions : 103

2015 Revenue in Millions : 106

Growth (%) : -3

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Savella

Pharmtech & Ingredients

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Milnacipran HCl

Main Therapeutic Indication : CNS & Anesthesia

Currency : USD

2019 Revenue in Millions : 89

2018 Revenue in Millions : 85

Growth (%) : 4

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info